首页> 外文期刊>BMC Public Health >High prevalence of hepatitis B infections in Burkina Faso (1996–2017): a systematic review with meta-analysis of epidemiological studies
【24h】

High prevalence of hepatitis B infections in Burkina Faso (1996–2017): a systematic review with meta-analysis of epidemiological studies

机译:布基纳法索的乙型肝炎感染率高(1996-2017年):对流行病学研究进行荟萃分析的系统评价

获取原文
           

摘要

Hepatitis B virus (HBV) infection was long considered an important public health concern in Burkina Faso and still represents a major cause of liver cancer and cirrhosis in the active population. To counter the problem, a national strategic plan was developed and adopted in July 2017 to coordinate viral hepatitis elimination’s efforts. However evidence to support its implementation remains scanty and scattered. The main purpose of this study was to summarize available information from per-reviewed articles published over the last two decades to accurately estimate the prevalence of HBV infection in Burkina Faso. We conducted a systematic search with meta-analysis of scientific articles using Science-Direct, Web-of-Science, PubMed/Medline, and Google Scholar. We systematically assessed all relevant publications that measured the prevalence of hepatitis B surface antigen and which were published between 1996 and 2017. We estimated the national HBV prevalence and its 95% confident interval. We subsequently adjusted the meta-analysis to possible sources of heterogeneity. We retrieved and analyzed a total of 22 full text papers including 99,672 participants. The overall prevalence was 11.21%. The prevalence after adjustment were 9.41%, 11.11%, 11.73% and 12.61% in the general population, pregnant women, blood donors and HIV-positive persons respectively. The prevalence was higher before implementation of HBV universal vaccination and decreased from 12.80% between 1996 and 2001 to 11.11% between 2012 and 2017. The prevalence was also higher in rural area 17.35% than urban area 11.11%. The western regions were more affected with 12.69% than the central regions 10.57%. The prevalence was 14.66% in the boucle of Mouhoun region and 14.59 in the center-west region. Aggregate data were not available for the other regions. HBV has clearly an important burden in Burkina Faso as described by its high prevalence and this problem significantly challenges the national health care system. There is an urgent need for effective public health interventions to eliminate the problem. However, higher quality data are needed to produce reliable epidemiological estimates that will guide control efforts towards the achievement of the national strategic plan’s goals.
机译:长期以来,乙型肝炎病毒(HBV)感染在布基纳法索一直被视为重要的公共卫生问题,并且仍然是活跃人群肝癌和肝硬化的主要原因。为了解决这个问题,2017年7月制定并通过了一项国家战略计划,以协调消除病毒性肝炎的工作。但是,支持其实施的证据仍然很少且分散。这项研究的主要目的是总结过去二十年来发表的每篇评论文章的可用信息,以准确估算布基纳法索的HBV感染率。我们使用Science-Direct,Science-of-Science,PubMed / Medline和Google Scholar对科学文章进行了荟萃分析,从而进行了系统的搜索。我们系统地评估了所有测量乙型肝炎表面抗原发生率的相关出版物,这些出版物于1996年至2017年之间发表。我们估算了全国HBV流行率及其95%的置信区间。随后,我们将荟萃分析调整为可能的异质性来源。我们检索并分析了22篇全文论文,包括99,672名参与者。总体患病率为11.21%。调整后的患病率在普通人群,孕妇,献血者和艾滋病毒阳性患者中分别为9.41%,11.11%,11.73%和12.61%。实施HBV通用疫苗之前的患病率较高,从1996年至2001年的12.80%降至2012年至2017年的11.11%。农村地区的患病率也比城市地区的11.11%高。西部地区受影响最大,为12.69%,中部地区为10.57%。在Mouhoun地区的河床患病率为14.66%,在中西部地区为14.59。没有其他地区的汇总数据。正如其高流行所描述的那样,乙肝病毒显然是布基纳法索的一个重要负担,这一问题极大地挑战了国家卫生保健系统。迫切需要有效的公共卫生干预措施来消除这一问题。但是,需要更高质量的数据来生成可靠的流行病学估计值,以指导控制工作以实现国家战略计划的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号